Corrigendum: Determination of CSF GFAP, CCN5, and vWF levels enhances the diagnostic accuracy of clinically defined MS from non-MS patients with CSF oligoclonal bands
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-12-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1095038/full |
| _version_ | 1811293641636839424 |
|---|---|
| author | Fay Probert Tianrong Yeo Tianrong Yeo Tianrong Yeo Yifan Zhou Yifan Zhou Yifan Zhou Megan Sealey Siddharth Arora Jacqueline Palace Timothy D. W. Claridge Rainer Hillenbrand Johanna Oechtering Jens Kuhle David Leppert Daniel C. Anthony |
| author_facet | Fay Probert Tianrong Yeo Tianrong Yeo Tianrong Yeo Yifan Zhou Yifan Zhou Yifan Zhou Megan Sealey Siddharth Arora Jacqueline Palace Timothy D. W. Claridge Rainer Hillenbrand Johanna Oechtering Jens Kuhle David Leppert Daniel C. Anthony |
| author_sort | Fay Probert |
| collection | DOAJ |
| first_indexed | 2024-04-13T05:04:33Z |
| format | Article |
| id | doaj.art-75b59a542ce04643b4bcfa4d18406134 |
| institution | Directory Open Access Journal |
| issn | 1664-3224 |
| language | English |
| last_indexed | 2024-04-13T05:04:33Z |
| publishDate | 2022-12-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj.art-75b59a542ce04643b4bcfa4d184061342022-12-22T03:01:13ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-12-011310.3389/fimmu.2022.10950381095038Corrigendum: Determination of CSF GFAP, CCN5, and vWF levels enhances the diagnostic accuracy of clinically defined MS from non-MS patients with CSF oligoclonal bandsFay Probert0Tianrong Yeo1Tianrong Yeo2Tianrong Yeo3Yifan Zhou4Yifan Zhou5Yifan Zhou6Megan Sealey7Siddharth Arora8Jacqueline Palace9Timothy D. W. Claridge10Rainer Hillenbrand11Johanna Oechtering12Jens Kuhle13David Leppert14Daniel C. Anthony15Department of Chemistry, University of Oxford, Oxford, United KingdomDepartment of Pharmacology, University of Oxford, Oxford, United KingdomDepartment of Neurology, National Neuroscience Institute, Singapore, SingaporeDuke-National University of Singapore (NUS) Medical School, Singapore, SingaporeDepartment of Pharmacology, University of Oxford, Oxford, United KingdomTranslational Stem Cell Biology Branch, National Institutes of Health, Bethesda, MD, United StatesWellcome Medical Research Council (MRC) Trust Stem Cell Institute, University of Cambridge, Cambridge, United KingdomDepartment of Pharmacology, University of Oxford, Oxford, United KingdomDepartment of Mathematics, University of Oxford, Oxford, United KingdomNuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, United KingdomDepartment of Chemistry, University of Oxford, Oxford, United KingdomBiomarker Development, Novartis Pharma AG, Basel, Switzerland0Neurologic Clinic and Policlinic, Multiple Sclerosis (MS) Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Clinical Research and Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland0Neurologic Clinic and Policlinic, Multiple Sclerosis (MS) Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Clinical Research and Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland0Neurologic Clinic and Policlinic, Multiple Sclerosis (MS) Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Clinical Research and Biomedicine, University Hospital Basel, University of Basel, Basel, SwitzerlandDepartment of Pharmacology, University of Oxford, Oxford, United Kingdomhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.1095038/fulldiagnosismetabolomics (OMICS)multiple sclerosis (MS)proteomicsoligoclonal bandbiomarker |
| spellingShingle | Fay Probert Tianrong Yeo Tianrong Yeo Tianrong Yeo Yifan Zhou Yifan Zhou Yifan Zhou Megan Sealey Siddharth Arora Jacqueline Palace Timothy D. W. Claridge Rainer Hillenbrand Johanna Oechtering Jens Kuhle David Leppert Daniel C. Anthony Corrigendum: Determination of CSF GFAP, CCN5, and vWF levels enhances the diagnostic accuracy of clinically defined MS from non-MS patients with CSF oligoclonal bands Frontiers in Immunology diagnosis metabolomics (OMICS) multiple sclerosis (MS) proteomics oligoclonal band biomarker |
| title | Corrigendum: Determination of CSF GFAP, CCN5, and vWF levels enhances the diagnostic accuracy of clinically defined MS from non-MS patients with CSF oligoclonal bands |
| title_full | Corrigendum: Determination of CSF GFAP, CCN5, and vWF levels enhances the diagnostic accuracy of clinically defined MS from non-MS patients with CSF oligoclonal bands |
| title_fullStr | Corrigendum: Determination of CSF GFAP, CCN5, and vWF levels enhances the diagnostic accuracy of clinically defined MS from non-MS patients with CSF oligoclonal bands |
| title_full_unstemmed | Corrigendum: Determination of CSF GFAP, CCN5, and vWF levels enhances the diagnostic accuracy of clinically defined MS from non-MS patients with CSF oligoclonal bands |
| title_short | Corrigendum: Determination of CSF GFAP, CCN5, and vWF levels enhances the diagnostic accuracy of clinically defined MS from non-MS patients with CSF oligoclonal bands |
| title_sort | corrigendum determination of csf gfap ccn5 and vwf levels enhances the diagnostic accuracy of clinically defined ms from non ms patients with csf oligoclonal bands |
| topic | diagnosis metabolomics (OMICS) multiple sclerosis (MS) proteomics oligoclonal band biomarker |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1095038/full |
| work_keys_str_mv | AT fayprobert corrigendumdeterminationofcsfgfapccn5andvwflevelsenhancesthediagnosticaccuracyofclinicallydefinedmsfromnonmspatientswithcsfoligoclonalbands AT tianrongyeo corrigendumdeterminationofcsfgfapccn5andvwflevelsenhancesthediagnosticaccuracyofclinicallydefinedmsfromnonmspatientswithcsfoligoclonalbands AT tianrongyeo corrigendumdeterminationofcsfgfapccn5andvwflevelsenhancesthediagnosticaccuracyofclinicallydefinedmsfromnonmspatientswithcsfoligoclonalbands AT tianrongyeo corrigendumdeterminationofcsfgfapccn5andvwflevelsenhancesthediagnosticaccuracyofclinicallydefinedmsfromnonmspatientswithcsfoligoclonalbands AT yifanzhou corrigendumdeterminationofcsfgfapccn5andvwflevelsenhancesthediagnosticaccuracyofclinicallydefinedmsfromnonmspatientswithcsfoligoclonalbands AT yifanzhou corrigendumdeterminationofcsfgfapccn5andvwflevelsenhancesthediagnosticaccuracyofclinicallydefinedmsfromnonmspatientswithcsfoligoclonalbands AT yifanzhou corrigendumdeterminationofcsfgfapccn5andvwflevelsenhancesthediagnosticaccuracyofclinicallydefinedmsfromnonmspatientswithcsfoligoclonalbands AT megansealey corrigendumdeterminationofcsfgfapccn5andvwflevelsenhancesthediagnosticaccuracyofclinicallydefinedmsfromnonmspatientswithcsfoligoclonalbands AT siddhartharora corrigendumdeterminationofcsfgfapccn5andvwflevelsenhancesthediagnosticaccuracyofclinicallydefinedmsfromnonmspatientswithcsfoligoclonalbands AT jacquelinepalace corrigendumdeterminationofcsfgfapccn5andvwflevelsenhancesthediagnosticaccuracyofclinicallydefinedmsfromnonmspatientswithcsfoligoclonalbands AT timothydwclaridge corrigendumdeterminationofcsfgfapccn5andvwflevelsenhancesthediagnosticaccuracyofclinicallydefinedmsfromnonmspatientswithcsfoligoclonalbands AT rainerhillenbrand corrigendumdeterminationofcsfgfapccn5andvwflevelsenhancesthediagnosticaccuracyofclinicallydefinedmsfromnonmspatientswithcsfoligoclonalbands AT johannaoechtering corrigendumdeterminationofcsfgfapccn5andvwflevelsenhancesthediagnosticaccuracyofclinicallydefinedmsfromnonmspatientswithcsfoligoclonalbands AT jenskuhle corrigendumdeterminationofcsfgfapccn5andvwflevelsenhancesthediagnosticaccuracyofclinicallydefinedmsfromnonmspatientswithcsfoligoclonalbands AT davidleppert corrigendumdeterminationofcsfgfapccn5andvwflevelsenhancesthediagnosticaccuracyofclinicallydefinedmsfromnonmspatientswithcsfoligoclonalbands AT danielcanthony corrigendumdeterminationofcsfgfapccn5andvwflevelsenhancesthediagnosticaccuracyofclinicallydefinedmsfromnonmspatientswithcsfoligoclonalbands |